Entropy Technologies LP cut its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 19.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,112 shares of the medical research company's stock after selling 5,207 shares during the period. Entropy Technologies LP's holdings in Agilent Technologies were worth $2,470,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC increased its stake in shares of Agilent Technologies by 3.0% in the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company's stock worth $403,000 after buying an additional 102 shares during the period. Cary Street Partners Financial LLC increased its stake in shares of Agilent Technologies by 2.9% in the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company's stock worth $431,000 after buying an additional 103 shares during the period. Western Pacific Wealth Management LP boosted its holdings in Agilent Technologies by 15.2% in the first quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company's stock valued at $102,000 after acquiring an additional 115 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its holdings in Agilent Technologies by 5.1% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company's stock valued at $281,000 after acquiring an additional 116 shares in the last quarter. Finally, Brighton Jones LLC boosted its holdings in Agilent Technologies by 2.6% in the first quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company's stock valued at $560,000 after acquiring an additional 121 shares in the last quarter.
Analyst Upgrades and Downgrades
A has been the topic of a number of research reports. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Saturday, June 28th. Robert W. Baird decreased their target price on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Evercore ISI boosted their target price on Agilent Technologies from $125.00 to $130.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research report on Thursday, May 29th. Finally, TD Cowen upped their price target on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $139.77.
View Our Latest Stock Report on Agilent Technologies
Agilent Technologies Stock Up 0.1%
NYSE A traded up $0.12 during trading on Friday, hitting $118.99. The company's stock had a trading volume of 308,275 shares, compared to its average volume of 1,965,405. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. The company has a market cap of $33.80 billion, a PE ratio of 29.37, a P/E/G ratio of 3.65 and a beta of 1.22. The business's 50 day simple moving average is $117.76 and its 200-day simple moving average is $118.72. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84.
Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.05. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. During the same quarter last year, the company earned $1.22 earnings per share. The company's quarterly revenue was up 6.0% on a year-over-year basis. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st were given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.8%. The ex-dividend date was Tuesday, July 1st. Agilent Technologies's dividend payout ratio (DPR) is currently 24.44%.
Insiders Place Their Bets
In other news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares in the company, valued at $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access